Biodegradable ocular implants
First Claim
Patent Images
1. A method for treating an eye condition which comprises:
- introducing into at least one of the anterior or posterior chamber of an eye at least one microencapsulated drug as particles of not greater than about 2mm, said particles comprising said drug and a pharmacologically acceptable biodegradable polymer or liposome which is degraded in the eye.
10 Assignments
0 Petitions
Accused Products
Abstract
Encapsulated drugs are employed for introduction into the chambers of the eye for therapeutic purposes. The administration of drugs is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outside the site of administration.
590 Citations
17 Claims
-
1. A method for treating an eye condition which comprises:
introducing into at least one of the anterior or posterior chamber of an eye at least one microencapsulated drug as particles of not greater than about 2mm, said particles comprising said drug and a pharmacologically acceptable biodegradable polymer or liposome which is degraded in the eye. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
15. A method for treating an eye condition which comprises:
introducing into an anterior chamber of an eye a composition of matter comprising liposomes enclosing in their lumen an isotonic solution comprising a pharmacologically active agent which is slowly released in the eye. - View Dependent Claims (16, 17)
Specification